Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Nov 14, 2026
TickeronGET DAILY SIGNALS
Nutrien Ltd. (NTR): Is a +14% Gain to the $81 Target Realistic?

Nutrien Ltd. (NTR): Is a +14% Gain to the $81 Target Realistic?

Key Takeaways

  • The central price target used here is $81, the arithmetic mean of ten recent, individually verified analyst price targets that sit above Nutrien's current share price.
  • Across all valid targets reviewed — roughly 26 covering Nutrien — the overall average is about $77, within a wide range of roughly $62 to $90.
  • The stock traded near $71.24 in mid-November 2026, implying a required gain of roughly 14% to reach $81, a modest move by equity-market standards.
  • The strongest supporting factors are recovering fertilizer fundamentals, an attractive dividend yield near 3%, and a forward P/E below the broader market.
  • The biggest risks are volatile potash, nitrogen, and phosphate prices, soft global crop-input demand, and significant disagreement among analysts.
  • Analyst views span from Sell to Buy, underscoring how much depends on commodity price direction rather than company execution alone.
  • For more detail on this ticker's Major News, Today's Price Move, Forecast, and Earnings, explore the dedicated pages available for additional context.
  • Readers can also explore Trending AI Robots to see how automated strategies are interpreting current market conditions.

Analyst Price Targets and Consensus View

Nutrien Ltd. (NTR), the Saskatoon, Canada-based crop-input producer operating across Potash, Nitrogen, Phosphate, and Retail segments, carries a "Buy" consensus but with unusually wide dispersion. The overall average of roughly 26 targets is near $77, with a low around $62 and a high near $90. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Because that overall average sits less than 10% above the latest price, the $81 central target is instead the average of only the verified targets above the current price. Recent above-price targets include RBC Capital at $85, CIBC at $85, TD Cowen at $83, BMO Capital at $82, Bank of America Securities at $80, J.P. Morgan at $80, BNP Paribas at $80, Oppenheimer at $78, Barclays at $78, and Morgan Stanley at $76.

The spread reflects genuine disagreement. Bullish analysts emphasize tightening global potash supply and improving nitrogen economics, while cautious voices — including at least one Sell-rated view — flag that fertilizer pricing remains well below 2022 peaks and that retail volumes depend on farm income and weather. Several firms raised targets during 2026 before trimming them as commodity prices pulled back, a pattern worth watching.

Current Market Position and Path Toward the Target

With the stock near $71.24, reaching $81 requires about a 14% advance. Nutrien trades at roughly 14–15 times forward earnings and offers a forward dividend of $2.20 per share, a yield near 3%, while the 52-week range spans $54.52 to $85.36. Trailing EPS stands near $4.58. From what I see, the setup looks measured rather than explosive.

A move toward $81 would likely depend less on valuation re-rating and more on confirmation that potash and nitrogen prices are stabilizing at higher levels and that 2027 earnings estimates — currently in the low $5 range per share — are achievable. The stock has already recovered substantially from its 52-week low, so incremental gains may require fresh earnings evidence rather than sentiment alone.

What Could Support a Move Toward the Target

  • Fertilizer pricing: Improved potash fundamentals and firmer nitrogen values directly support Nutrien's largest earnings drivers.
  • Income appeal: A dividend yield near 3% can attract investors during uncertain equity markets.
  • Valuation: A forward P/E around 14 is modest for a diversified agricultural-input leader.
  • Analyst revisions: Positive target increases through 2026 signal building confidence in a commodity recovery.
  • Scale and diversification: The Retail segment provides a buffer against pure commodity-price swings.

What Could Prevent the Target From Being Reached

  • Commodity weakness: Falling potash, nitrogen, or phosphate prices would pressure earnings and targets quickly.
  • Demand softness: Lower farm incomes, weak crop prices, or adverse weather can cut input purchases.
  • Guidance risk: Any downward revision to 2027 expectations could compress the multiple.
  • Valuation ceiling: Cyclical names often trade at lower multiples as commodity cycles mature.
  • Analyst disagreement: The wide $62-to-$90 range shows the market is far from unanimous on the recovery.

Technical Levels and Market Structure

The 52-week high near $85.36 stands out as the most meaningful overhead reference point, effectively capping the $81 target. The stock's recovery from the $54.52 low has been steady, and the $68–$70 zone has acted as support during recent pullbacks. A sustained move through the mid-$70s toward $81 would bring the $85 resistance level into focus, a psychologically important area where prior rallies stalled.

Time Horizon and What Investors Should Monitor

Analyst price targets generally reflect a roughly 12-month horizon, though individual firms apply different methodologies. Key items to watch include quarterly earnings (the next fiscal-year report is expected in February 2027), guidance on potash and nitrogen volumes, and any analyst target revisions. Broader inputs such as global grain prices, energy costs, interest rates, and currency moves in the Canadian dollar also matter for this globally diversified producer.

Final Assessment

Can Nutrien reach $81? The target, representing the average of analyst price targets above the current price, sits about 14% above the latest quote — a plausible but not guaranteed move. Support comes from recovering fertilizer fundamentals, an attractive dividend, and reasonable valuation, while the principal obstacles are commodity-price volatility and an unusually wide analyst range from roughly $62 to $90. The overall mean of all targets near $77 underscores that the higher $81 figure reflects only the more constructive views. Investors should monitor fertilizer pricing, upcoming earnings guidance, and analyst revisions rather than treat any single number as a certainty.

Exploring AI Tools in My Research Process

In my own analysis, I frequently rely on Tickeron’s AI Daily Buy/Sell Signals to track momentum shifts across commodity-exposed names. The platform continuously monitors thousands of stocks and ETFs, delivering AI-driven Buy, Sell, or Hold signals that help flag changes in technical behavior and market conditions more efficiently than manual reviews. For a cyclical stock like Nutrien, these signals can highlight when fertilizer price trends are beginning to influence price action. AI Daily Buy/Sell Signals

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: NTR

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


NTR in -1.32% downward trend, sliding for three consecutive days on November 12, 2026

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where NTR declined for three days, in 196 of 283 cases, the price declined further within the following month. The odds of a continued downward trend are 69%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on NTR as a result. In 57 of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 69%.

The Moving Average Convergence Divergence Histogram (MACD) for NTR turned negative on November 17, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In 33 of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at 67%.

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for NTR's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

Following a +4.17% 3-day Advance, the price is estimated to grow further. Considering data from situations where NTR advanced for three days, in 229 of 323 cases, the price rose further within the following month. The odds of a continued upward trend are 71%.

NTR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 162 of 223 cases where NTR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 73%.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 49 (best 1 - 100 worst), indicating steady price growth. NTR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is 55 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 71 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.317) is normal, around the industry mean (-0.492). P/E Ratio (14.470) is within average values for comparable stocks, (8.794). NTR's Projected Growth (PEG Ratio) (1.982) is slightly higher than the industry average of (0.867). Dividend Yield (0.031) settles around the average of (0.113) among similar stocks. P/S Ratio (1.329) is also within normal values, averaging (1.476).

The Tickeron SMR rating for this company is 73 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 91 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NTR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.

Notable companies

The most notable companies in this group are CF Industries Holding (NYSE:CF), Mosaic Company (The) (NYSE:MOS).

Industry description

The agricultural chemicals sector includes companies that produce chemical products for the agricultural industry applications like crop protection, animal health, biotechnology and pharmaceutical-related products. Some of the largest agricultural chemicals producers include Nutrien Ltd., Corteva Inc., and FMC Corporation.

Market Cap

The average market capitalization across the Chemicals: Agricultural Industry is 6.12B. The market cap for tickers in the group ranges from 611 to 34.11B. NTR holds the highest valuation in this group at 34.11B. The lowest valued company is BHILQ at 611.

High and low price notable news

The average weekly price growth across all stocks in the Chemicals: Agricultural Industry was -10%. For the same Industry, the average monthly price growth was -16%, and the average quarterly price growth was -28%. SMG experienced the highest price growth at -2%, while CTVA experienced the biggest fall at -31%.

Volume

The average weekly volume growth across all stocks in the Chemicals: Agricultural Industry was 40%. For the same stocks of the Industry, the average monthly volume growth was -22% and the average quarterly volume growth was 51%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 39
P/E Growth Rating: 50
Price Growth Rating: 64
SMR Rating: 80
Profit Risk Rating: 84
Seasonality Score: -32 (-100 ... +100)
Paper Trades 3
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a producer of fertilizers and other crop production supplies

Industry ChemicalsAgricultural

Industry
Chemicals Agricultural
Address
211 19th Street East
Phone
+1 306 933-8500
Employees
25100
Web
https://www.nutrien.com
Interact to see
Advertisement
UNH dropped -7.80% to $359.29 from Tuesday's $389.68 close, extending a two-session decline to roughly -13% and touching its lowest level in about seven weeks; the move occurred during regular market hours. The selloff accelerated on the CMS "CRUSH" proposal unveiled Nov. 16, which would extrapolate Medicare Advantage risk-adjustment audit findings from samples across entire contracts back to payment year 2018 and drop the fee-for-service adjuster; CMS estimates roughly $9 billion in industry clawbacks per payment year, and UnitedHealth, the largest MA insurer, has not sized its exposure.
AMD jumped +2.42%, rising $12.81 to $542.95 from Wednesday's close of $530.14, in early regular-session trading Thursday after extending gains built during premarket. The catalyst was Anthropic's IPO, priced at $83 a share above its marketed range and raising $81.3 billion in the largest listing on record; the debut revived sentiment across AI hardware names, and AMD is both an Anthropic supplier and a $2.5 billion investor in the lab.
Cerebras Systems (CBRS) dropped -6.48% to $97.43 in regular trading from the prior close of $104.18, reversing an early premarket gain of roughly +3%. No verified news or fundamental catalyst found for the intraday reversal; the move is likely profit-taking after the stock's +21% post-earnings rebound, consistent with a name that averages a ±4.5% daily swing and remains 65% below its first-day close.
SDD is an inverse leveraged ETF (exchange-traded fund) built to return roughly -2x the daily move of the S&P SmallCap 600 Index, making it a tactical hedging tool rather than a long-term holding. XXX is an asset-allocation ETF that blends roughly 75% S&P 500 large-cap equities with a 25% sleeve of XRP, a major cryptocurrency, aiming for capital appreciation.
KLAR dropped -4.84% to $13.75 from Wednesday's close of $14.45, with the decline occurring during Thursday's regular session. JPMorgan downgraded the shares to Hold from Overweight and cut its price target to $17 from $20 in a note published before the open, extending a run of post-earnings target reductions.
Nutrien Ltd. (NTR): Is a +14% Gain to the $81 Target Realistic?